| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0037 | 1 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |